about
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced lat...
Read More
220.61
-2.94
(-1.32%)
1.4M
XNYS Volume
XNYS 14 Nov, 2025 4:30 PM (EST)
High Financial Strength
Expensive Valuation
Technically Moderately Bullish
Expensive Star
These stocks are bullish in nature, strong in quality and technical aspects, but bad in valuations. Investors need to be cautious on their returns earned.
View Similar
Embed DVM
IQVIA Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..